SGHT: sightsciences.com Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand sightsciences.com (SGHT)

Sight Sciences, Inc. (SGHT) is implementing eco-friendly standards by reducing plastic in ophthalmic devices. The current PEG ratio visualizes these environmental achievements, while the 0.00 mark indicates the metric's current state. Micro-instrument assembly production capacities are operating at maximum efficiency with ideal wear and tear. Financial stability is growing alongside the popularity of glaucoma treatment systems, despite high development investments.

Sight Sciences, Inc. (SGHT) - PEG Multiple from 07/04/2022 to 11/13/2026

Sight Sciences, Inc. (SGHT) - metric breakdowns and financial figures

- current price and projected stock value:
Fundamental company analysis:SGHT (Sight Sciences Inc.)
Manufactured products of sightsciences.com

The investment attractiveness of Sight Sciences, Inc. (SGHT) is based on a combination of market expectations and operational logistics efficiency, which ensures the seamless delivery of ophthalmological equipment. By analyzing the relationship between valuation and earnings dynamics, an investor observes the result of dividing the P/E ratio by the earnings growth rate, where a value below one signals that the asset is undervalued relative to its expansion, despite the risk of capital stagnation.

Competing companies

Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Corp) - Price/Earnings to Growth Multiple|RxSight Ophthalmic - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate stereotaxis.com STXS|Price/Earnings to Growth Ratio Neuronetics (STIM)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|IVF - Growth-Adjusted Market Cap to Net Income|BBLG (Bone Biologics Corp) - PEG Multiple|Axonics Inc. (AXNX) - Growth-Adjusted Market Cap to Net Income|PEG Multiple BIOL|dynatronics.com (DYNT) - Price to Net Income Growth Ratio|PEG Multiple FNA (Paragon 28)|Growth-Adjusted Payback Ratio INVO